← Open Payments lookup

ANDREW LERMAN: Open Payments

NPI 1407173974 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$51,700 in 246 payments from 39 companies in 2025. Trend: 2023 $68,910 · 2024 $64,855 · 2025 $51,700

Speaker / faculty: $22,490Honoraria: $12,310Consulting: $7,255Food & beverage: $5,140Travel & lodging: $3,358Education: $1,148
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.30$19,445
Amneal Pharmaceuticals LLC25$9,793
ARGENX US, INC.14$6,073
MDD US Operations, LLC19$5,802
Neurelis, Inc.12$5,126
UCB, Inc.17$2,612
ABBVIE INC.32$533
PFIZER INC.12$219
TG Therapeutics, Inc.5$209
Takeda Pharmaceuticals U.S.A., Inc.9$203

Products named: INGREZZA, CREXONT, VYVGART, Gocovri, VALTOCO, Rystiggo, Briviact, BRIUMVI.

Industry payments across FL — which companies pay providers there.